BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Tumor response
1
Comparative study between Embosphere® and Marine gel® as embolic agents for chemoembolization of hepatocellular carcinoma
1/11/2024 6:17:31 AM | Browse: 251 | Download: 729
2
Lenvatinib combined with sintilimab plus transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma
1/11/2024 5:28:09 AM | Browse: 335 | Download: 1160
3
Hyperthermia combined with chemotherapy vs chemotherapy in patients with advanced pancreatic cancer: A multicenter retrospective observational comparative study
6/21/2023 2:14:18 AM | Browse: 349 | Download: 1260
4
Tumor irradiation may facilitate the detection of tumor-specific mutations in plasma
12/24/2021 9:38:39 AM | Browse: 681 | Download: 1651
5
Disease control and failure patterns of unresectable hepatocellular carcinoma following transarterial radioembolization with yttrium-90 microspheres and with/without sorafenib
12/17/2021 8:56:01 AM | Browse: 609 | Download: 1485
6
Modulated electro-hyperthermia in stage III and IV pancreatic cancer: Results of an observational study on 158 patients
11/19/2021 9:32:33 AM | Browse: 609 | Download: 1691
7
Role of imaging in evaluating the response after neoadjuvant treatment for pancreatic ductal adenocarcinoma
6/8/2021 10:51:03 AM | Browse: 763 | Download: 1734
8
Immuno-response evaluation criteria in solid tumors in the assessment of atypical response after immunotherapy
5/22/2021 10:39:22 AM | Browse: 613 | Download: 1636
9
Disease control with sunitinib in advanced intrahepatic cholangiocarcinoma resistant to gemcitabine-oxaliplatin chemotherapy
5/1/2015 7:01:00 PM | Browse: 1317 | Download: 2145
Write to the Help Desk
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345